Introduction
Cerebral oxygenation can be monitored non-invasively with the use of near-infrared spectroscopy (NIRS) to determine brain regional oxygen saturation (rSO 2 ). In post-cardiac arrest patients, there is often global cerebral ischaemia contributing to neurological dysfunction. Targeted temperature management (TTM) is often implemented to limit neurological injury caused by the hypoxia during cardiac arrest and help improve survival, as shown in the Hypothermia after Cardiac Arrest Study Group trial. 1 During TTM post-cardiac arrest, it is crucial to optimize cerebral perfusion to achieve good neurological recovery. We present a case where the use of cerebral oximetry monitoring post-cardiac arrest led to the early detection of cerebral hypoperfusion and discuss its implications on management and outcome.
Timeline

Case presentation
A 60-year-old Chinese male presented to the hospital with acute shortness of breath and lower limb swelling. He has a past medical history of stroke disease, chronic kidney disease, and ischaemic cardiomyopathy with a mildly reduced left ventricular ejection fraction of 45%. His cardiovascular risk factors include diabetes mellitus, hypertension, and hyperlipidaemia.
Clinical examination revealed bibasal crepitations with bilateral pitting oedema. The blood pressure on admission was 150/87 mmHg with sinus tachycardia with a heart rate of 129 beats per minute.
Initial arterial blood gas (ABG) on admission ( Table 1) revealed Type 2 respiratory failure, while chest X-ray done showed bilateral pulmonary congestion.
He was initially started on non-invasive ventilation and intravenous frusemide and glyceryl trinitrate infusion. Despite initial clinical improvement, the patient became increasingly restless with
Clinical events
Admission
Patient admitted for acute pulmonary oedema with Type 2 respiratory failure and started on trial of non-invasive ventilation 
Learning points
• During post-cardiac arrest care, haemodynamic changes, ventilation strategies, and therapeutic hypothermia may lead to a decrease in cerebral blood flow.
• Cerebral oximetry offers real-time monitoring of brain tissue oxygenation and serves as a safety measure during targeted temperature management and haemodynamic and ventilator titration.
• Cerebral oximetry can help in the early detection of cerebral hypoperfusion and prevent secondary brain injury. worsening hypoxaemia and decision was made for intubation and mechanical ventilation. However, he suffered a pulseless electrical activity cardiac arrest peri-intubation with a low-flow time of 20 min before return of spontaneous circulation (ROSC). He was started on our institution's protocolized post-cardiac arrest care bundle ( Figure 1 ) which included continuous rSO 2 monitoring and TTM with mild induced hypothermia at 33 C. An oesophageal probe was inserted for core body temperature monitoring. Initial ABG post-ROSC revealed a Type 2 respiratory failure with pH 7.14, pCO 2 54, pO 2 110, HCO 3 18, and SaO 2 97%. Patient was sedated and paralyzed and ventilator settings were optimized to correct the respiratory acidosis. Patient was ventilated with a tidal volume of 7 mL/kg predicted body weight and at a ventilator rate of 28 breaths per minute. Initial cerebral oximetry revealed an rSO 2 66% (left) and 67% (right).
Post-resuscitation SpO 2 was maintained above 94% and mean arterial pressure (MAP) was constantly above 80 mmHg without the need for inotropes or vasopressors. However, it was subsequently noted that the cerebral rSO 2 had decreased to 33% (left) and 35% (right) and a repeat ABG showed resolution of the respiratory acidosis with pH 7.3, pCO 2 33, pO 2 138, HCO 3 16, and SaO 2 99%.
Ventilator settings were immediately adjusted and the minute ventilation reduced by lowering the ventilator rate to aim for mild therapeutic hypercapnia with a target pCO 2 of 50-55 mmHg. 2 PEEP was reduced from 12 cmH 2 O to avoid an excessively high intrathoracic pressure which may impede cerebral venous drainage. Patient was also started on dobutamine infusion to improve the global and cerebral perfusion as the central venous oxygen saturation (ScvO 2 ) of 62% reflected a systemic oxygen delivery/consumption mismatch, while a Pcv-aCO 2 gap of 14 mmHg suggested a low-flow state. The above interventions resulted in an improvement in cerebral rSO 2 to 55% (left) and 51% (right) ( Table 2) .
Patient was cooled for 24 h and then gradually rewarmed. A repeat transthoracic echocardiogram revealed severe global hypokinesia with a left ventricular ejection fraction of 26%.
He was subsequently extubated after 6 days in the cardiac intensive care unit with improvement in Glasgow coma scale score and underwent rehabilitation in the general ward. On discharge, he had a cerebral performance category of 1 and is now on follow-up in the outpatient clinic. 
Discussion
It is important to optimize cerebral perfusion after ROSC to improve the number of neurologically intact survivors. There have been studies looking at the correlation of cerebral rSO 2 during resuscitation and successful ROSC and it has also been shown that a high rSO 2 on arrival at the hospital predicted good 90-day neurologic outcomes. 1, 3, 4 However, equally important to a successful ROSC is the care the patient receives after admission to the intensive care unit. There have been limited tools to guide optimization of cerebral oxygenation during post-cardiac arrest care. Targeted temperature management is an essential part of the post-ROSC care in cardiac arrest patients and it has been shown to increase the chance of survival with favourable neurological outcomes. 1 However, during post-cardiac arrest care, there may be a drop in mean arterial pressure and cardiac output leading to a drop in cerebral blood flow. 5 Ventilation strategies including the use of neuromuscular blocking agents together with the reduction of metabolism during therapeutic hypothermia 6 also reduce pCO 2 which is a major regulator of cerebrovascular tone. Accidental hypocapnia can occur and result in adverse cerebral vasoconstriction and cerebral ischaemia. 7, 8 This may not be detected early as neurological function is difficult to assess clinically when the patient is sedated and paralyzed during TTM.
Conclusion
Cerebral oximetry offers real-time and dynamic monitoring of brain tissue oxygenation and can potentially serve as a safety measure during the hemodynamic and ventilatory management of patients post-cardiac arrest. 9 Cerebral oximetry may be the answer to assessing cerebral perfusion during the crucial period of TTM and aid in preventing secondary iatrogenic brain injury. More studies can be done to assess the morbidity and mortality benefit of cerebral rSO 2 monitoring during post-cardiac arrest care, its accuracy in assessing cerebral ischaemia and the cut-off values which would signify sufficient cerebral perfusion to impact good neurological recovery.
